Skip to main content
NIH funding notice RFA-DK-19-021

Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)

Closed on June 26, 2020.

Posted
January 2, 2020
Close date
June 26, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,325,011 in first-year total cost, median $662,506.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-1 (O3)]2

Most frequent institutions

  1. NEMOURS CHILDREN'S CLINIC1
  2. SCRIPPS HEALTH1
Competing awards under RFA-DK-19-021 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-Age Families1R01DK127493-01PATTON, SUSANA RNEMOURS CHILDREN'S CLINIC, FL$672,233ZDK1
2020ACT1VATE: Addressing Emotional Distress to Improve Outcomes among Diverse Adults with Type 1 Diabetes1R01DK127491-01FORTMANN, ADELAIDE LPHILIS-TSIMIKAS, ATHENASCRIPPS HEALTH, CA$652,778ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.